Threadneedle launches the Threadneedle (Lux) Asian Equity Income Fund, a Luxembourg SICAV, to complement its existing range of dividend funds and respond to investors’ strong demand for income in a low-interest rate environment.
The fund is a conversion of the existing Threadneedle (Lux) Asia Fund and now seeks to provide income as well as capital appreciation by investing in selected high quality companies from Asia that deliver attractive dividends and sustainable growth. The fund will seek to achieve a yield in excess of the index. It is managed by George Gosden, Asian Equity Fund Manager at Threadneedle.
This fund complements Threadneedle’s existing range of equity income products and will take a similar approach to the Threadneedle Global Equity Income Fund in seeking out quality income stocks. Launched in 2007, the Threadneedle Global Equity Income Fund has a strong track record, outperforming the peer group* over 1, 3 and 5 years (as at 31 Dec 2012).
Mr Gosden will draw on the ideas from 11 fund managers and analysts in Threadneedle’s Asia and Emerging Markets Equity team, as well as the Global Equity team.
George Gosden, Fund Manager, said: “With this fund, I am looking for quality income stocks in Asia’s relatively high-growth environment. These are companies which are both growing their businesses, as well as delivering a sustainable and increasing yield.
“Dividend growth is expected to continue to accelerate in the Asian region over the coming year supported by robust corporate earnings growth and income generating opportunities can be found across the broad spectrum of countries and sectors in the region. Within ASEAN countries many companies are boosting dividends as they benefit from strong domestic consumption growth whilst elsewhere more cyclical companies are poised to benefit from any recovery in global growth. In addition the adoption of more progressive capital management and governance policies further underpin the outlook for dividends in the region.”
Fonds Kategorien und KAGs
Heute im Fokus
Sanofi lässt bei Medivation nicht locker. Merck & Co kommt zum Jahresstart in Schwung. Kia unterstützt Kaufprämie für E-Autos. Deutlich mehr prekäre Kredite Wells Fargo. Börsengang der Bahn 'vom Tisch'. Barclays wirft Ballast ab. Repsol trotzt niedrigen Ölpreisen. Höhere Kosten lasten auf Fitbit-Gewinn.
Diese Aktien sind auf den Verkauflisten der Experte
Das haben die Dax-Vorstände 2015 verdient
Diese Aktien sind auf den Kauflisten der Experten